Liver Failure: Clinical Trials

10 trials for Liver Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 unknown. 10 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Unknown 10
Phase 22Unknown 2

Follow Liver Failure: new trials by email Literature Review of Liver Failure trials Research Report on Liver Failure

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication
traditional Chinese medicine1 and traditional Chinese medicine 2 - Hepatic Encephalopathy, Cirrhosis, Liver
Phase 3UnknownQianfoshan Hospital2762021-12-012021-11-19
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
Terlipressin plus standard care, Standard care - Terlipressin Adverse Reaction, Ascites Hepatic
Phase 3UnknownShanghai Zhongshan Hospital862019-11-072020-01-09
Plasma Exchange in Acute on Chronic Liver Failure
Plasma exchange, Standard medical treatment - Cirrhosis, Liver, Acute-On-Chronic Liver Failure
Phase 3UnknownAsian Institute of Gastroenterology, India1302019-08-152019-08-09
Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis
GCSF, CD133 Cells Transplantation - End Stage Liver Disease
Phase 3UnknownNational University Hospital, Singapore662017-08-242021-01-19
Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy
Nitazoxanide, Lactulose - Encephalopathy, Hepatic
Phase 2 / Phase 3UnknownSherief Abd-Elsalam1202016-01-012017-08-21
The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)
Somatostatin - Liver Failure
Phase 3UnknownKorea University Anam Hospital202015-07-012016-09-12
ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study
probiotic VSL#3 - Hepatic Encephalopathy
Phase 3UnknownA.O. Ospedale Papa Giovanni XXIII502013-03-012013-02-25
Effect of Intermittent Hepatic Inflow Occlusion During Donor Hepatectomy In Living Donor Liver Transplantation
Intermittent hepatic inflow occlusion (IHIO) - End Stage Liver Disease, Living Donor
Phase 3UnknownSamsung Medical Center502008-07-012010-07-28
Citrate Anticoagulation During MARS Treatment
trisodiumcitrate - Liver Failure
Phase 2 / Phase 3UnknownUniversitaire Ziekenhuizen KU Leuven102008-07-012009-03-05
Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage
Lactulose, Placebo - Hepatocerebral Encephalopathy, Portal-Systemic Encephalopathy
Phase 3UnknownAga Khan University1282007-11-012007-11-05

Narrower conditions

Hepatic Encephalopathy (4)  ·  End Stage Liver Disease (2)  ·  Liver Cirrhosis (2)  ·  Acute Kidney Injury (1)  ·  Acute-On-Chronic Liver Failure (1)

Broader conditions

Digestive System Diseases (10)  ·  Hepatic Insufficiency (10)  ·  Liver Diseases (10)  ·  Brain Diseases (4)  ·  Brain Diseases, Metabolic (4)  ·  Central Nervous System Diseases (4)  ·  Metabolic Diseases (4)  ·  Nervous System Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Fibrosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Lactulose (2)  ·  Plasma Exchange (1)  ·  Somatostatin (1)  ·  Standard of Care (1)  ·  Terlipressin (1)  ·  nitazoxanide (1)

Sponsors

A.O. Ospedale Papa Giovanni XXIII (1)  ·  Aga Khan University (1)  ·  Asian Institute of Gastroenterology, India (1)  ·  Korea University Anam Hospital (1)  ·  National University Hospital, Singapore (1)  ·  Qianfoshan Hospital (1)  ·  Samsung Medical Center (1)  ·  Shanghai Zhongshan Hospital (1)  ·  Sherief Abd-Elsalam (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)

Countries

China (2)  ·  South Korea (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Italy (1)  ·  Pakistan (1)  ·  Singapore (1)

Top investigators

Alexander Wilmer, MD, PhD (1)  ·  Asem Elfert, Prof (1)  ·  Bjorn Meijers, MD (1)  ·  Dan Yock Young (1)  ·  Dong-Sik Kim, Professor (1)  ·  Frederik Nevens, MD, PhD (1)  ·  Hui-Chuan Sun, MD&PhD (1)  ·  Jae-Won Joh, MD., PhD (1)  ·  Mark Muthiah (1)  ·  Mennat-Allah Elsawaf, lecturer (1)  ·  Mohammad Salih, FCPS (1)  ·  Pieter Evenepoel, MD, PhD (1)  ·  Samah Soliman, lecturer (1)  ·  Shahid Ahmed, FCPS (1)

Results publications

PMID 21837746

NIH funding

2016 (1)